| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,040 |
12,851 |
$1.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,340 |
5,096 |
$692K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,910 |
2,851 |
$318K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,563 |
2,514 |
$306K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,748 |
2,666 |
$299K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,787 |
1,655 |
$179K |
| 92552 |
|
5,914 |
5,782 |
$148K |
| 90686 |
|
3,692 |
3,516 |
$84K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,068 |
4,933 |
$52K |
| 96127 |
|
7,137 |
6,971 |
$44K |
| D1206 |
Topical application of fluoride varnish |
1,523 |
1,505 |
$38K |
| 87428 |
|
731 |
716 |
$25K |
| 90698 |
|
1,052 |
1,033 |
$24K |
| 99177 |
|
4,706 |
4,578 |
$24K |
| 90670 |
|
1,024 |
1,005 |
$23K |
| 94760 |
|
13,041 |
11,849 |
$18K |
| 87430 |
|
1,246 |
1,187 |
$16K |
| 92587 |
|
876 |
835 |
$15K |
| 99173 |
|
5,861 |
5,738 |
$15K |
| 90651 |
|
354 |
354 |
$9K |
| 96160 |
|
3,496 |
3,414 |
$8K |
| 90680 |
|
308 |
304 |
$7K |
| 94375 |
|
216 |
210 |
$7K |
| 90656 |
|
288 |
285 |
$7K |
| 90633 |
|
278 |
275 |
$6K |
| 90716 |
|
266 |
254 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
564 |
203 |
$5K |
| W7000 |
|
1,013 |
998 |
$5K |
| 90707 |
|
215 |
205 |
$5K |
| 90734 |
|
194 |
194 |
$5K |
| 90621 |
|
184 |
184 |
$4K |
| 88738 |
|
1,018 |
997 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
98 |
96 |
$4K |
| 0072A |
|
107 |
107 |
$4K |
| 0071A |
|
101 |
100 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
75 |
75 |
$3K |
| 96161 |
|
1,307 |
1,112 |
$3K |
| 90619 |
|
124 |
117 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
267 |
255 |
$3K |
| 2015F |
|
278 |
276 |
$3K |
| 87400 |
|
430 |
174 |
$3K |
| 90744 |
|
119 |
114 |
$3K |
| 90661 |
|
131 |
128 |
$3K |
| 83655 |
|
203 |
198 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
147 |
142 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$2K |
| 87420 |
|
146 |
137 |
$2K |
| 87807 |
|
92 |
90 |
$967.00 |
| 90677 |
|
36 |
36 |
$915.28 |
| 90715 |
|
28 |
28 |
$651.84 |
| 94664 |
|
58 |
57 |
$511.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
52 |
52 |
$410.00 |
| 83718 |
|
54 |
54 |
$380.52 |
| 90696 |
|
12 |
12 |
$279.36 |
| 90620 |
|
12 |
12 |
$279.36 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
149 |
143 |
$248.32 |
| 82465 |
|
54 |
54 |
$180.52 |
| 36416 |
|
467 |
395 |
$180.00 |
| 81002 |
|
65 |
62 |
$171.80 |
| A7015 |
Aerosol mask, used with dme nebulizer |
91 |
85 |
$155.37 |
| 85018 |
|
68 |
61 |
$152.37 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
105 |
101 |
$12.65 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
30 |
28 |
$1.20 |
| 91307 |
|
76 |
64 |
$0.07 |
| 99072 |
|
69 |
68 |
$0.00 |